Identification of HER2 inhibitors from curcumin derivatives using combination of <i>in silico</i> screening and molecular dynamics simulation-Reference-Cited by-同舟云学术

Identification of HER2 inhibitors from curcumin derivatives using combination of in silico screening and molecular dynamics simulation

Published:2023-02-08 Issue:21 Volume:41 Page:12328-12337
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Saibu Oluwatosin A.¹^ORCID,Singh Gagandeep²³^ORCID,Olugbodi Sunday A.¹,Oluwafemi Adenrele T.⁴,Ajayi Temitope M.⁴,Hammed Sodiq O.⁵,Oladipo Oladapo O.⁵,Odunitan Tope T.⁴,Omoboyowa Damilola A.⁶^ORCID

Affiliation:

1. Department of Environmental Toxicology, Universitat Duisburg-Essen, North Rhine-Westphalia, Germany

2. Section of Microbiology, Central Ayurveda Research Institute, Jhansi, Uttar Pradesh, India

3. Kusuma School of Biological Sciences, Indian Institute of Technology, Delhi, New Delhi, India

4. Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria

5. Department of Physiology, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria

6. Department of Biochemistry, Adekunle Ajasin University, Ondo State, Nigeria

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2023.2175260

Reference47 articles.

1. In-silico studies of glutathione peroxidase4 activators as candidate for multiple sclerosis management

2. Genetics of breast cancer: management strategies and risk-reducing surgery

3. Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer

4. Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials

5. The changing global patterns of female breast cancer incidence and mortality

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in HER2-Targeted Therapies: From monoclonal antibodies to dual inhibitors developments in cancer treatment;Bioorganic Chemistry;2024-10

2. Virtual screening and molecular dynamics simulation of natural compounds as potential inhibitors of serine/threonine kinase 16 for anticancer drug discovery;Molecular Diversity;2024-07-20

3. Virtual Screening and Molecular Dynamics Simulation of Natural Compounds as Potential Inhibitors of Serine/Threonine Kinase 16 for Anticancer Drug Discovery;2024-04-09

4. Molecular docking and molecular dynamics approach to identify EGFR and HER2 receptors inhibitory effect of compounds in Zanthoxylum simulans Hance;Vietnam Journal of Chemistry;2024-02

5. Computational insights into overcoming resistance mechanisms in targeted therapies for advanced breast cancer: focus on EGFR and HER2 co-inhibition;Journal of Biomolecular Structure and Dynamics;2024-01-17